Cargando…
Physical Agent-Based Treatments for Overactive Bladder: A Review
Almost one-fifth of the people in the world experience a decrease in quality of life due to overactive bladder (OAB) syndrome. The main bothersome symptoms are urgency accompanied by urinary frequency and nocturia. This chronic, disabling condition is first managed by reducing fluid intake and pelvi...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456779/ https://www.ncbi.nlm.nih.gov/pubmed/36079076 http://dx.doi.org/10.3390/jcm11175150 |
_version_ | 1784785903182413824 |
---|---|
author | Khasanah, Nurida Chin, Hung-Yen Peng, Chih-Wei |
author_facet | Khasanah, Nurida Chin, Hung-Yen Peng, Chih-Wei |
author_sort | Khasanah, Nurida |
collection | PubMed |
description | Almost one-fifth of the people in the world experience a decrease in quality of life due to overactive bladder (OAB) syndrome. The main bothersome symptoms are urgency accompanied by urinary frequency and nocturia. This chronic, disabling condition is first managed by reducing fluid intake and pelvic floor muscle training, supplemented with antimuscarinic drugs, if necessary. However, refractory cases often still occur. In more severe cases, invasive surgical interventions can be considered; yet, the success rate is still inconsistent, and there is a high complication rate. This condition is frustrating for patients and challenging for the medical staff involved. Although its pathophysiology has not been fully elucidated, peripheral autonomic somatic and sensory afferent receptors are considered to be involved in this condition. Hence, currently, physical agent-based treatments such as neuromodulation have taken a significant place in the third-line therapy of OAB. The efficacy and safety profiles of electrical and magnetic stimulation continue to evolve. Physical-based agents provide an appealing option owing to their effectiveness and minimal side effects. In addition, more physical therapies using light and shock energy are currently being investigated. Thus, a comprehensive understanding of these modalities is an extremely important aspect to provide the most suitable modalities for patients. |
format | Online Article Text |
id | pubmed-9456779 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-94567792022-09-09 Physical Agent-Based Treatments for Overactive Bladder: A Review Khasanah, Nurida Chin, Hung-Yen Peng, Chih-Wei J Clin Med Review Almost one-fifth of the people in the world experience a decrease in quality of life due to overactive bladder (OAB) syndrome. The main bothersome symptoms are urgency accompanied by urinary frequency and nocturia. This chronic, disabling condition is first managed by reducing fluid intake and pelvic floor muscle training, supplemented with antimuscarinic drugs, if necessary. However, refractory cases often still occur. In more severe cases, invasive surgical interventions can be considered; yet, the success rate is still inconsistent, and there is a high complication rate. This condition is frustrating for patients and challenging for the medical staff involved. Although its pathophysiology has not been fully elucidated, peripheral autonomic somatic and sensory afferent receptors are considered to be involved in this condition. Hence, currently, physical agent-based treatments such as neuromodulation have taken a significant place in the third-line therapy of OAB. The efficacy and safety profiles of electrical and magnetic stimulation continue to evolve. Physical-based agents provide an appealing option owing to their effectiveness and minimal side effects. In addition, more physical therapies using light and shock energy are currently being investigated. Thus, a comprehensive understanding of these modalities is an extremely important aspect to provide the most suitable modalities for patients. MDPI 2022-08-31 /pmc/articles/PMC9456779/ /pubmed/36079076 http://dx.doi.org/10.3390/jcm11175150 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Khasanah, Nurida Chin, Hung-Yen Peng, Chih-Wei Physical Agent-Based Treatments for Overactive Bladder: A Review |
title | Physical Agent-Based Treatments for Overactive Bladder: A Review |
title_full | Physical Agent-Based Treatments for Overactive Bladder: A Review |
title_fullStr | Physical Agent-Based Treatments for Overactive Bladder: A Review |
title_full_unstemmed | Physical Agent-Based Treatments for Overactive Bladder: A Review |
title_short | Physical Agent-Based Treatments for Overactive Bladder: A Review |
title_sort | physical agent-based treatments for overactive bladder: a review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456779/ https://www.ncbi.nlm.nih.gov/pubmed/36079076 http://dx.doi.org/10.3390/jcm11175150 |
work_keys_str_mv | AT khasanahnurida physicalagentbasedtreatmentsforoveractivebladderareview AT chinhungyen physicalagentbasedtreatmentsforoveractivebladderareview AT pengchihwei physicalagentbasedtreatmentsforoveractivebladderareview |